The Janssen Pharmaceutical Companies of Johnson & Johnson are dedicated to addressing and solving some of the most important unmet medical needs of our time in oncology, immunology, neuroscience, infectious diseases and vaccines, and cardiovascular and metabolic diseases.

Driven by our commitment to patients, we bring innovative products, services and solutions to people throughout the world. We recognize the impact of serious conditions on people's lives, and we aim to empower people through disease awareness, education and access to quality care.

Our research and development strategy focuses on identifying medical needs and harnessing the best science in the world, whether from our own laboratories or through strategic relationships and collaborations. We leverage our world-class discovery and development expertise and operational excellence to deliver innovative, effective solutions in five therapeutic areas:
Cardiovascular and metabolic disorders
Immunology
Infectious diseases and vaccines
Neuroscience
Oncology

Research Grants 17 show all


$908.3K
2008

$4.6M
2009

$7.1M
2011

$22.3M
2014

$23.5M
2015

Patents 5,033show all

  • 1,127
    C07K - Peptides
  • 1,053
    A61K - Preparations for medical, dental, or toilet purposes
  • 493
    C12N - Microorganisms or enzymes
  • 241
    G01N - Investigating or analysing materials by determining their chemical or physical properties
  • 167
    C07D - Heterocyclic compounds
  • 85
    Y02A - Technologies for adaptation to climate change
  • 78
    C12Q - Measuring or testing processes involving enzymes, nucleic acids or microorganisms
  • 63
    A01K - Animal husbandry
  • 58
    C40B - Combinatorial chemistry
  • 53
    A61P - Specific therapeutic activity of chemical compounds or medicinal preparations

Clinical Trials 159show all

50Phase 331Phase 223Phase 19Phase 48Phase 1/Phase 27Other

Contact Information

Horsham, PA
United States